arrow
F

Filippo Milano

Fred Hutchinson Cancer Center
H指数:32
被引数:4,134

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comprehensive, simplified, and objective comorbidity assessment before allogeneic hematopoietic cell transplantation: a comparative cohort study

异基因造血干细胞移植前的全面、简化和客观的合并症评估:一项比较队列研究

2026-10-150
OA
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age

单倍型与匹配无关供者移植联合移植后环磷酰胺:基于平台的机器学习分析供者年龄

Leukemia
IF13.4
2026-04-150
OAAI
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials

Gamma-分泌酶抑制剂对BCMA CAR-T疗法后多发性骨髓瘤结局的影响:两项I期试验的比较

2025-09-080
PRE
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis

供者巨细胞病毒血清学状态在采用异基因供者造血细胞移植并接受术后环磷酰胺预防的巨细胞病毒血清学阴性受者中的作用

2025-05-140
PRE
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation

供者年龄和供者巨细胞病毒血清状态对亲属供者异基因造血干细胞移植后结局的影响

2025-03-120
PRE
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant CyclophosphamideBased Graft-Versus-Host Disease Prophylaxis

供体类型不影响低强度异基因造血细胞移植后的晚期移植失败,移植后基于环磷酰胺的移植物抗宿主病预防

2025-03-010
PRE
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target (vol 132, e157101, 2022)
2024-08-150
OAAI
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

anti-PD-L1抗体起始时间影响CD19 car-t细胞治疗大b细胞淋巴瘤的疗效/毒性

2024-01-2311
OAAI